Menu
Recruiting NCT07150559

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection

No phase Interventional Acute Type A Aortic Dissection Hypothermia Total Aortic Arch Replacement Frozen Elephant Trunk

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Arch-Clamping Technique under Mild Hypothermia, Arch-Clamping Technique under Moderate Hypothermia, Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest.
Who it may be relevant to
Registry conditions: Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement, Frozen Elephant Trunk. Basic parameters: 18 years — 70 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection: Study Protocol for a Multicenter, Three-arm, Open-label, Randomized, Parallel-controlled Trial

Overview

The study is a multicenter, three-arm, open-label, randomized, parallel-controlled trial, which plans to enroll 306 participants diagnosed with acute type A aortic dissection (ATAAD) from 7 hospitals in China. All patients receive total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation and are randomized to Group 1 (arch-clamping technique under mild hypothermia), Group 2 (arch-clamping technique under moderate hypothermia) and Group 3 (Sun's procedure using bilateral antegrade cerebral perfusion) in the ratio of 1:1:1. After a 1-year follow-up, the validity and safety of the mild hypothermic arch-clamping technique for ATAAD was evaluated via the incidence of major adverse events including death, renal replacement therapy, stroke, and paraplegia, as well as times of circulatory arrest, cardiopulmonary bypass, and mechanical ventilation, and length of ICU stay.

Interventions

  • Procedure Arch-Clamping Technique under Mild Hypothermia
    This procedure is performed under mild hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allows bilateral antegrade cerebral perfusion (bACP) through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end f
  • Procedure Arch-Clamping Technique under Moderate Hypothermia
    This procedure is performed under moderate hypothermia. The branch arteries of the arch are reconstructed using the side arms of a Y-shaped graft, which allow bACP through the right axillary artery. A FET is deployed in the descending aorta and clamped together with the autologous aorta immediately, then distal perfusion is restored through the femoral artery. After the proximal procedures are completed, the distal anastomosis is performed in an end-to-end fashion. Finally, the main trunk of the
  • Procedure Total Arch Replacement combined Frozen Elephant Trunk Implantation using Bilateral Antegrade Cerebral Perfusion under Moderate Hypothermic Circulatory Arrest
    This procedure is performed using bACP under MHCA, which involves FET deployment in the descending aorta followed by total arch replacement with a four-branched vascular graft. Deployment of the FET and suture of the distal anastomosis are completed during bACP. MHCA is terminated and distal reperfusion is initiated once the distal anastomosis is completed, and the left carotid artery is reconstructed first (after which bACP is stopped, rewarming is started and the brain is perfused bilaterally)

Primary outcome measures

  • Major adverse events [Time frame: Thirty days and 12 months after the operation]
Secondary outcome measures (4)
  • Circulatory arrest time [Time frame: During surgery]
  • Cardiopulmonary bypass time [Time frame: During surgery]
  • Mechanical ventilation time [Time frame: Discharge / 30 days after operation]
  • The length of ICU stay [Time frame: Discharge / 30 days after operation]

Eligibility criteria

Inclusion criteria

  • Aortic CTA confirmed as ATAAD according to the 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease;
  • Adult patients (18-70 years) weighing 50-120 kg;
  • Time interval between the onset of symptoms and operation is less than 14 days;
  • Indications for total aortic arch replacement are available;
  • Signed informed consent and availability for follow-up.

Exclusion criteria

  • History of chronic renal failure, hepatocirrhosis, and hepatic insufficiency;
  • Severe gastrointestinal complications of non-aortic dissection, such as mesenteric ischemia, gastrointestinal bleeding, hepatopancreaticobiliary dysfunction, and intestinal obstruction;
  • History of severe cerebral infarction (with cerebral infarction sequels);
  • Preoperative intubation or unconsciousness;
  • Inflammatory aortic diseases, such as Takayasu arteritis and Behçet's disease, etc;
  • History of infectious aortic diseases;
  • History of cardiac and aortic surgery;
  • History of malignancy or previous radiotherapy;
  • Pregnant or feeding women, or anyone planning to reproduce during the test period;
  • Without an informed consent signature;
  • Participating in any other clinical trial;
  • Having other causes not eligible for operation.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

China · 1 center
  • Beijing Anzhen Hospital — Beijing

Identifiers

NCT: NCT07150559 · 2023ZD0504402

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗